Screener
Bausch + Lomb BLCO Devices — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch + Lomb in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001860742-26-000088
| (in millions) | Vision Care / Three Months Ended June 30, 2026 | Vision Care / Three Months Ended June 30, 2025 | Pharmaceuticals / Three Months Ended June 30, 2026 | Pharmaceuticals / Three Months Ended June 30, 2025 | Surgical / Three Months Ended June 30, 2026 | Surgical / Three Months Ended June 30, 2025 | Total / Three Months Ended June 30, 2026 | Total / Three Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|---|---|
| Pharmaceuticals | $1 | $1 | $299 | $259 | — | — | $300 | $260 |
| Devices | 270 | 258 | — | — | 254 | 214 | 524 | 472 |
| OTC | 497 | 482 | — | — | — | — | 497 | 482 |
| Branded and Other Generics | 13 | 10 | 55 | 48 | — | — | 68 | 58 |
| Other revenues | 3 | 2 | — | 2 | 2 | 2 | 5 | 6 |
| $784 | $753 | $354 | $309 | $256 | $216 | $1,394 | $1,278 | |
| Six Months Ended June 30, | ||||||||
| 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch + Lomb's devices — total revenues?
- Bausch + Lomb (BLCO) reported devices — total revenues of $524M in Q2 2026.
- How has Bausch + Lomb's devices — total revenues changed year-over-year?
- Bausch + Lomb's devices — total revenues increased by 11.0% year-over-year, from $472M to $524M.
- What is the long-term trend for Bausch + Lomb's devices — total revenues?
- Over 4 years (2021 to 2025), Bausch + Lomb's devices — total revenues has grown at a 4.8% compound annual growth rate (CAGR), from $1.6B to $1.92B.
- What does devices — total revenues mean?
- This metric represents the total gross revenue generated from the sale of surgical equipment, intraocular lenses, and related medical devices within the company's surgical segment. It serves as a primary indicator of market penetration and demand for the firm's specialized ophthalmic hardware and surgical solutions. Tracking this figure helps investors assess the segment's growth trajectory and its contribution to the overall corporate revenue mix.
Ask your AI about Bausch + Lomb's devices — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude